California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on April 27, 2026

Apr. 27, 2026

Addgene Reinforces Its Expanding Role in Research with New Brand

Indeterminate GlobeNewswire

Apr. 27, 2026

Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platform

Indeterminate GlobeNewswire

Apr. 27, 2026

WellSpan Behavioral Health Walk-In Crisis Center opens in York

Indeterminate GlobeNewswire

Apr. 27, 2026

Sharecare surpasses 1 million hours of home care delivered to Veterans through U.S. Department of Veterans Affairs Community Care Network

Indeterminate GlobeNewswire

Apr. 27, 2026

Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies

Indeterminate GlobeNewswire

Apr. 27, 2026

Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

MS Canada Calls on Canadians to Take Action During MS Awareness Month Towards a World Free of MS

Indeterminate GlobeNewswire

Apr. 27, 2026

NEXGEL Appoints Ian Blackman as Chief Financial Officer

Indeterminate GlobeNewswire

Apr. 27, 2026

Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program

Indeterminate GlobeNewswire

Apr. 27, 2026

TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call

Indeterminate GlobeNewswire

Apr. 27, 2026

Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload

Indeterminate GlobeNewswire

Apr. 27, 2026

CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer

Indeterminate GlobeNewswire

Apr. 27, 2026

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

TOMI Environmental Solutions, Inc. Sees Strong Interest In Its Solutions at INTERPHEX 2026 

Indeterminate GlobeNewswire

Apr. 27, 2026

Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015

Indeterminate GlobeNewswire

Apr. 27, 2026

Solana Company (NASDAQ: HSDT) Announces Registered Direct Offering of Common Stock to Global Institutional Investor

Indeterminate GlobeNewswire

Apr. 27, 2026

MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling

Indeterminate GlobeNewswire

Apr. 27, 2026

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

Indeterminate GlobeNewswire